Expression and regulation of antimicrobial peptide psoriasin (S100A7) at the ocular surface and in the lacrimal apparatus

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 7, 2011, Pages 4914-4922

  Garreis, Fabian ^a,b   Gottschalt, Maria ^b   Schlorf, Thomas ^b   Gläser, Regine ^c   Harder, Jürgen ^c   Worlitzsch, Dieter ^b   Paulsen, Friedrich P ^a,b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; MESSENGER RNA; PSORIASIN; VASCULOTROPIN; PROTEIN S 100; RNA; S100A7 PROTEIN, MOUSE;

ADULT; AGED; ANTIMICROBIAL ACTIVITY; ARTICLE; CONJUNCTIVA EPITHELIUM; CONTROLLED STUDY; CORNEA; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; EYE; EYELID; FEMALE; HAEMOPHILUS INFLUENZAE; HAIR FOLLICLE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNITY; IMMUNOHISTOCHEMISTRY; LACRIMAL APPARATUS; LACRIMAL DUCT; LACRIMAL FLUID; MALE; MEIBOMIAN GLAND; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS REGULATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAPHYLOCOCCUS AUREUS; WESTERN BLOTTING; BIOSYNTHESIS; CELL CULTURE; COMPARATIVE STUDY; CONJUNCTIVA; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CELLS, CULTURED; CONJUNCTIVA; CORNEA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; LACRIMAL APPARATUS; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; S100 PROTEINS; TEARS;

EID: 80052366492     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-6598     Document Type: Article

References (58)

1. Sack RA, Nunes I, Beaton A, Morris C. Host-defense mechanism of the ocular surfaces. Biosci Rep. 2001;21:463-480.
2. Sack RA, Conradi L, Krumholz D, Beaton A, Sathe S, Morris C. Membrane array characterization of 80 chemokines, cytokines, and growth factors in open-and closed-eye tears: angiogenin and other defense system constituents. Invest Ophthalmol Vis Sci. 2005;46:1228-1238.
3. McDermott AM. The role of antimicrobial peptides at the ocular surface. Ophthalmic Res. 2009;41:60-75.
4. Paulsen FVD, Steven P, Pufe T. Antimicrobial peptides at the ocular surface. In: Zierhut M, Stern ME, Sullivan DA, eds. Immunology of Lacrimal Gland and Tear Film. London: Taylor & Francis; 2005: 97-104.
5. Garreis F, Gottschalt M, Paulsen FP. Antimicrobial peptides as a major part of the innate immune defense at the ocular surface. Dev Ophthalmol. 2010;45:16-22.
6. Kumar A, Yin J, Zhang J, Yu FS. Modulation of corneal epithelial innate immune response to pseudomonas infection by flagellin pretreatment. Invest Ophthalmol Vis Sci. 2007;48:4664-4670.
7. Huang LC, Jean D, Proske RJ, Reins RY, McDermott AM. Ocular surface expression and in vitro activity of antimicrobial peptides. Curr Eye Res. 2007;32:595-609.
8. Huang LC, Petkova TD, Reins RY, Proske RJ, McDermott AM. Multifunctional roles of human cathelicidin (LL-37) at the ocular surface. Invest Ophthalmol Vis Sci. 2006;47:2369-2380.
9. McIntosh RS, Cade JE, Al-Abed M, et al. The spectrum of antimicrobial peptide expression at the ocular surface. Invest Ophthalmol Vis Sci. 2005;46:1379-1385.
10. Ikeda A, Sakimoto T, Shoji J, Sawa M. Expression of alpha-and beta-defensins in human ocular surface tissue. Jpn J Ophthalmol. 2005;49:73-78.
11. McDermott AM, Redfern RL, Zhang B, Pei Y, Huang L, Proske RJ. Defensin expression by the cornea: multiple signalling pathways mediate IL-1beta stimulation of hBD-2 expression by human corneal epithelial cells. Invest Ophthalmol Vis Sci. 2003;44:1859-1865.
12. Haynes RJ, McElveen JE, Dua HS, Tighe PJ, Liversidge J. Expression of human beta-defensins in intraocular tissues. Invest Ophthalmol Vis Sci. 2000;41:3026-3031.
13. Haynes RJ, Tighe PJ, Dua HS. Antimicrobial defensin peptides of the human ocular surface. Br J Ophthalmol. 1999;83:737-741.
14. McNamara N, Van R, Tuchin OS, Fleiszig SM. Ocular surface epithelia express mRNA for human beta defensin-2. Exp Eye Res. 1999;69:483-490.
15. Abedin A, Mohammed I, Hopkinson A, Dua HS. A novel antimicrobial peptide on the ocular surface shows decreased expression in inflammation and infection. Invest Ophthalmol Vis Sci. 2008;49: 28-33.
16. Mohammed I, Suleman H, Otri AM, et al. Localisation and gene expression of human beta-defensin 9 at the human ocular surface epithelium. Invest Ophthalmol Vis Sci. 2010;51:4677-4682.
17. Otri AM, Mohammed I, Abedin A, et al. Antimicrobial peptides expression by ocular surface cells in response to Acanthamoeba castellanii: an in vitro study. Br J Ophthalmol. 2010;94:1523-1527.
18. Broome AM, Ryan D, Eckert RL. S100 protein subcellular localization during epidermal differentiation and psoriasis. J Histochem Cytochem. 2003;51:675-685.
19. Gläser R, Harder J, Lange H, Bartels J, Christophers E, Schröder JM. Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Nat Immunol. 2005;6:57-64.
20. Mischke D, Korge BP, Marenholz I, Volz A, Ziegler A. Genes encoding structural proteins of epidermal cornification and S100 calcium-binding proteins form a gene complex ("epidermal differentiation complex") on human chromosome 1q21. J Invest Dermatol. 1996;106:989-992.
21. South AP, Cabral A, Ives JH, et al. Human epidermal differentiation complex in a single 2.5 Mbp long continuum of overlapping DNA cloned in bacteria integrating physical and transcript maps. J Invest Dermatol. 1999;112:910-918.
22. Eckert RL, Broome AM, Ruse M, Robinson N, Ryan D, Lee K. S100 proteins in the epidermis. J Invest Dermatol. 2004;123:23-33.
23. Madsen P, Rasmussen HH, Leffers H, et al. Molecular cloning, occurrence, and expression of a novel partially secreted protein "psoriasin" that is highly up-regulated in psoriatic skin. J Invest Dermatol. 1991;97:701-712.
24. Alowami S, Qing G, Emberley E, Snell L, Watson PH. Psoriasin (S100A7) expression is altered during skin tumorigenesis. BMC Dermatol. 2003;3:1.
25. Lee KC, Eckert RL. S100A7 (Psoriasin): mechanism of antibacterial action in wounds. J Invest Dermatol. 2007;127:945-957.
26. Michalek M, Gelhaus C, Hecht O, et al. The human antimicrobial protein psoriasin acts by permeabilization of bacterial membranes. Dev Comp Immunol. 2009;33:740-746.
27. Niyonsaba F, Hattori F, Maeyama K, Ogawa H, Okamoto K. Induction of a microbicidal protein psoriasin (S100A7), and its stimulatory effects on normal human keratinocytes. J Dermatol Sci. 2008;52:216-219.
28. Gläser R, Navid F, Schuller W, et al. UV-B radiation induces the expression of antimicrobial peptides in human keratinocytes in vitro and in vivo. J Allergy Clin Immunol. 2009;123:1117-1123.
29. Hoffmann HJ, Olsen E, Etzerodt M, et al. Psoriasin binds calcium and is upregulated by calcium to levels that resemble those observed in normal skin. J Invest Dermatol. 1994;103:370-375.
30. Abtin A, Eckhart L, Mildner M, Gruber F, Schröder JM, Tschachler E. Flagellin is the principal inducer of the antimicrobial peptide S100A7c (psoriasin) in human epidermal keratinocytes exposed to Escherichia coli. FASEB J. 2008;22:2168-2176.
31. Jinquan T, Vorum H, Larsen CG, et al. Psoriasin: a novel chemotactic protein. J Invest Dermatol. 1996;107:5-10.
32. Zheng Y, Niyonsaba F, Ushio H, et al. Microbicidal protein psoriasin is a multifunctional modulator of neutrophil activation. Immunology. 2008;124:357-367.
33. Wolf R, Howard OM, Dong HF, et al. Chemotactic activity of S100A7 (psoriasin) is mediated by the receptor for advanced glycation end products and potentiates inflammation with highly homologous but functionally distinct S100A15. J Immunol. 2008;181:1499-1506.
34. Araki-Sasaki K, Ohashi Y, Sasabe T, et al. An SV40-immortalized human corneal epithelial cell line and its characterization. Invest Ophthalmol Vis Sci. 1995;36:614-621.
35. Diebold Y, Calonge M, Enriquez de Salamanca A, et al. Characterization of a spontaneously immortalized cell line (IOBA-NHC) from normal human conjunctiva. Invest Ophthalmol Vis Sci. 2003;44: 4263-4274.
36. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29:e45.
37. Porter D, Lahti-Domenici J, Keshaviah A, et al. Molecular markers in ductal carcinoma in situ of the breast. Mol Cancer Res. 2003;1:362-375.
38. Meyer JE, Harder J, Sipos B, et al. Psoriasin (S100A7) is a principal antimicrobial peptide of the human tongue. Mucosal Immunol. 2008;1:239-243.
39. Mildner M, Stichenwirth M, Abtin A, et al. Psoriasin (S100A7) is a major Escherichia coli-cidal factor of the female genital tract. Mucosal Immunol. 2010;3:602-609.
40. Schröder JM, Harder J. Innate antimicrobial peptides in the skin (in French). Med Sci (Paris). 2006;22:153-157.
41. Stoeckelhuber M, Messmer EM, Schubert C, et al. Immunolocalization of defensins and cathelicidin in human glands of Moll. Ann Anat. 2008;190:230-237.
42. Bräuer L, Kindler C, Jager K, et al. Detection of surfactant proteins A and D in human tear fluid and the human lacrimal system. Invest Ophthalmol Vis Sci. 2007;48:3945-3953.
43. Garreis F, Schlorf T, Worlitzsch D, et al. Roles of human betadefensins in innate immune defense at the ocular surface: arming and alarming corneal and conjunctival epithelial cells. Histochem Cell Biol. 2010;134:59-73.
44. Grus FH, Podust VN, Bruns K, et al. SELDI-TOF-MS ProteinChip array profiling of tears from patients with dry eye. Invest Ophthalmol Vis Sci. 2005;46:863-876.
45. Zhou L, Beuerman RW, Chan CM, et al. Identification of tear fluid biomarkers in dry eye syndrome using iTRAQ quantitative proteomics. J Proteome Res. 2009;8:4889-4905.
46. Kawasaki S, Kawamoto S, Yokoi N, et al. Up-regulated gene expression in the conjunctival epithelium of patients with Sjogren's syndrome. Exp Eye Res. 2003;77:17-26.
47. Zhou L, Beuerman RW, Ang LP, et al. Elevation of human alphadefensins and S100 calcium-binding proteins A8 and A9 in tear fluid of patients with pterygium. Invest Ophthalmol Vis Sci. 2009;50: 2077-2086.
48. Tong L, Zhou L, Beuerman RW, Zhao SZ, Li XR. Association of tear proteins with Meibomian gland disease and dry eye symptoms. Br J Ophthalmol. 2011;95:848-852.
49. Liu S, Richards SM, Lo K, Hatton M, Fay AM, Sullivan DA. Changes in gene expression in human meibomian gland dysfunction. Invest Ophthalmol Vis Sci. 2011;52:2727-2740.
50. Baum J. Infections of the eye. Clin Infect Dis. 1995;21:479-486; quiz 487-478.
51. Sung HK, Michael IP, Nagy A. Multifaceted role of vascular endothelial growth factor signaling in adult tissue physiology: an emerging concept with clinical implications. Curr Opin Hematol. 2010;17:206-212.
52. Epling J. Bacterial conjunctivitis. Clin Evid (Online). November 7,2007.
53. Leibovitch I, Lai TF, Senarath L, Hsuan J, Selva D. Infectious keratitis in South Australia: emerging resistance to cephazolin. Eur J Ophthalmol. 2005;15:23-26.
54. Li X, de Leeuw E, Lu W. Total chemical synthesis of human psoriasin by native chemical ligation. Biochemistry. 2005;44: 14688-14694.
55. Chen X, Niyonsaba F, Ushio H, et al. Synergistic effect of antibacterial agents human beta-defensins, cathelicidin LL-37 and lysozyme against Staphylococcus aureus and Escherichia coli. J Dermatol Sci. 2005;40:123-132.
56. Nagaoka I, Hirota S, Yomogida S, Ohwada A, Hirata M. Synergistic actions of antibacterial neutrophil defensins and cathelicidins. Inflamm Res. 2000;49:73-79.
57. Singh PK, Tack BF, McCray PB Jr, Welsh MJ. Synergistic and additive killing by antimicrobial factors found in human airway surface liquid. Am J Physiol Lung Cell Mol Physiol. 2000;279:L799-L805.
58. Knop E, Knop N, Millar T, Obata H, Sullivan DA. The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland. Invest Ophthalmol Vis Sci. 2011;52:1938-1978.